Moderna SE Asia partner says regional vaccine supplies booked to year-end

1 minute read

A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File Photo

Register now for FREE unlimited access to Reuters.com

SINGAPORE, June 29 (Reuters) - Zuellig Pharma, Moderna Inc's (MRNA.O) supply partner for COVID-19 vaccines in Southeast Asia, said on Tuesday that regional orders for the mRNA vaccine were almost fully booked for this year.

Singapore-headquartered Zuellig is involved in the distribution, regulatory approvals and purchase contracts for vaccines for use in Southeast Asia, Hong Kong, Macau and Taiwan.

"A lot of the transactions that are being done today will be for 2022 ... because the supply of Moderna vaccine is pretty much exhausted already for 2021," Zuellig CEO John Graham told Reuters.

Register now for FREE unlimited access to Reuters.com
Reporting by Aradhana Aravindan; Editing by Martin Petty

Our Standards: The Thomson Reuters Trust Principles.